NCT02833701 2023-10-24Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade GliomaUniversity of NebraskaPhase 1 Terminated9 enrolled
NCT01891747 2022-03-10A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade GliomaVanderbilt-Ingram Cancer CenterPhase 1 Completed14 enrolled